Employee Benefit News March 26, 2025
Bridget Mulvenna

Nearly a decade ago, plan sponsors’ pharmacy benefit conversations focused mostly on member satisfaction and plan compliance. Today, fiduciary duty comes first, then member satisfaction, compliance and, of course, GLP-1s, which is why employers are counting on their benefit advisers more than ever to guide them through Rx matters. Times have changed, which begs the question, “What does it take to ensure plan sponsors meet their fiduciary duty?”

Putting the pharmacy benefits manager (PBM) business “out to bid” every few years isn’t enough. Given heightened scrutiny of traditional PBMs and rising Employee Retirement Income Security Act (ERISA) liability risk, plan sponsors should regularly evaluate their PBM options, prioritizing strategies that lower total costs, improve member outcomes and safeguard long-term...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Pharma, Pharma / Biotech
The Case for 340B Done Right
Novo Nordisk Lands Lexicon Pharma Obesity Drug With Potential to Pair With GLP-1s
The Regimen: Portrayal of Pharmacists in Media
Independent Pharmacies Provide Personalized Care During COVID-19
Rare Metabolic Disease That Leads to Childhood Obesity Gets Its First FDA-Approved Drug

Share This Article